VIENNA (Reuters) – Swiss drugmaker Roche said on Sunday its rheumatoid arthritis medication Actemra for giant cell arteritis showed to be superior to steroids alone in maintaining steroid-free remission in a Phase III study.
To learn more visit: Reuters: Health News
The post Roche announces positive results for Actemra in phase III study appeared first on Online Medical Assistant Training Programs.
from WordPress https://onlinemedicalassistantprogramsedu.wordpress.com/2016/11/13/roche-announces-positive-results-for-actemra-in-phase-iii-study/
No comments:
Post a Comment